Are you a journalist? Please sign up here for our press releases
Subscribe to our monthly newsletter:
Molecular Genetics
06.09.2023
The complete, day 14 synthetic models may open new avenues of research into infertility, drug testing and growth of tissues for transplant – as...
17.08.2023
Viruses & Microorganisms, Molecular and Cell Biology, Immunology, Evolution and Development, Genetics
A newly discovered immune strategy protects bacteria and more advanced species, from corals to bees
28.06.2023
Viruses & Microorganisms, Molecular and Cell Biology, Immunology, Disease, Drugs & Diagnostics, Genetics
High levels of defensive proteins offer protection against a hostile takeover by herpes viruses
25.10.2022
Weizmann Institute scientists reveal how viruses outwit cellular immune systems
04.08.2022
Personalized Medicine, Nutrition, Viruses & Microorganisms, Immunology, Disease, Drugs & Diagnostics, Yeda Technology Transfer, Diagnostic Techniques and Drugs
A surprising precision weapon against Crohn’s and ulcerative colitis
01.08.2022
Stem Cells, Molecular and Cell Biology, Evolution and Development, Genetics, Technology & Applications
The method opens new vistas for studying how stem cells self-organize into organs and may in the future help produce transplantable...
12.07.2022
Removing a newly discovered “lock” from DNA’s packaging can restore limitless abilities to early cells
18.05.2022
Weizmann scientists breathe new life into one of the cell’s most classic and best-researched metabolic pathways
10.05.2022
New study reveals a genetic regulation mechanism in eukaryotes ensuring that proteins that work together are expressed together
25.04.2022
Viruses & Microorganisms, Disease, Drugs & Diagnostics, Technology & Applications, Yeda Technology Transfer, Benefiting Humanity, Biotechnology, Diagnostic Techniques and Drugs
FDA approves third-generation hepatitis B vaccine based on Weizmann research
